|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
3/22/2013 9:31:41 AM
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Kinetigen, Inc., a specialty pharmaceutical consulting firm with global reach, is pleased to announce the addition of Mark Sale, MD to its experienced team of drug development professionals. Dr. Sale strengthens Kinetigen’s core competencies in pharmacokinetics with his extensive background in modeling and simulation. “Dr. Sale is one of the pre-eminent pharmacometricians conducting modeling, simulation, and population PK analyses for pharmaceutical and biotech companies,” said Geoffrey Banks, Ph.D., Kinetigen President and CEO, adding further, “The addition of Dr. Sale as VP of Modeling and Simulation follows our strategic growth initiative to solidify our position as the go-to resource for clinical pharmacology, pharmacokinetics, and model based drug development in the pharmaceutical industry.”
|
|
|
|
|
|
|
|
|
|
|